Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06907680Phase 2Completed

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

Role: collaborator

NCT05939336Not ApplicableActive Not Recruiting

MOS Prebiotic Potential in Older Adults

Role: collaborator

NCT06285851Not ApplicableCompleted

A Novel Iron Supplement for Athletes: Phase I

Role: collaborator

NCT05524688Phase 1Terminated

Beta-glucan and Fatigue in HSCT Survivors

Role: collaborator

NCT03867591Not ApplicableCompleted

Fermented Soy and Heartburn Symptom Relief

Role: collaborator

All 5 trials loaded